Rhenman & Partners Asset Management AB - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$1,293,000
-82.0%
30,000
-87.0%
0.19%
-83.7%
Q1 2017$7,199,000
+14.0%
230,000
-8.0%
1.14%
-5.8%
Q4 2016$6,313,000
-99.9%
250,000
-7.4%
1.21%
+14.0%
Q3 2016$6,677,100,000
+116960.0%
270,000
-3.6%
1.06%
+4.7%
Q2 2016$5,704,000
+38.5%
280,000
+3.7%
1.01%
+24.0%
Q1 2016$4,118,000
+6.4%
270,000
-6.2%
0.82%
+39.7%
Q4 2015$3,871,000
-21.9%
288,000
-18.5%
0.58%
-25.9%
Q3 2015$4,957,000
-30.0%
353,328
-15.3%
0.79%
-7.1%
Q2 2015$7,081,000
+29.9%
417,000
-7.5%
0.85%
-7.5%
Q1 2015$5,450,000
+161.8%
450,800
+79.7%
0.92%
+52.4%
Q4 2014$2,082,000
+13.0%
250,800
+18.3%
0.60%
+11.9%
Q3 2014$1,842,000
-25.9%
212,000
-6.6%
0.54%
-27.0%
Q2 2014$2,486,000
+41.5%
227,000
+15.5%
0.74%
+40.0%
Q1 2014$1,757,000
+3.5%
196,537
-12.7%
0.53%
-20.6%
Q4 2013$1,697,000225,0000.66%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders